So, the natural question for Vir Biotechnology (NASDAQ:VIR) shareholders is whether they should be concerned by its rate of cash burn. In this article, we define cash burn as its annual (negative) ...
India continues to face an alarming rise in air- and water-borne diseases, driven by rapid urbanization, population growth, ...
MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company focused on ...
In fact, due to increased competition and other factors, Netflix's revenue growth dipped significantly and was in the low ...
Evercore 8th Annual Healthcare Conference December 3, 2025 2:35 PM ESTCompany ParticipantsSteven Harr - President, CEO ...
Aether Biomachines use an AI process to identify novel materials, then build them with biotechnology. They are the first ...
In October 2025, the U.S. Patent and Trademark Office (USPTO) launched the “Artificial Intelligence Search Automated Pilot Program,” or ASAP!, ...
Opinion
The Motley Fool on MSNOpinion
Prediction: The AI Boom Won't End in 2026 for This Simple Reason
We're at the beginning of a new AI wave.
Weinstein brings a global track record of transforming companies through value unlocking, and participation in over 20 M&A transactions and ...
That’s the big idea behind Zymosense, “The Nanoassay Company,” a startup that’s spinning off technology developed in the lab ...
Global Anatomic Pathology Market OverviewThe global anatomic pathology market is poised for a strong growth trajectory, expected to expand at a CAGR of nearly 8% during the forecast period. This ...
Analytica 2026 highlights the Green Lab agenda, focusing on resource conservation, innovative technologies, and best practices for sustainable laboratory work.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback